Linda King

Linda King FRSB is a virologist in the UK. She is Professor of Virology and Pro Vice-Chancellor for Research and Global Partnerships at Oxford Brookes University.

Education and career King was a student at the University of Liverpool graduating with a BSc in Biochemistry and Cell Biology, she studied for her doctorate in molecular virology at the University of Oxford graduating in 1985 and then worked as a postdoctoral researcher and junior research fellow at Linacre College. The following year she moved to Oxford Brookes to work as a lecturer in virology and subsequently rose to professor in 1998.

Research King's research looks at insect viruses and focusses on baculovirus expression systems

In 2006 King co-founded Oxford Expression Technologies, a spin out company of Oxford Brookes and NERC, which uses a Baculovirus-based protein expression platform to develop mammalian virus vaccines. In 2020 the company is involved in development of 'Covax-19', a vaccine against COVID-19.